Commercial
Deal-Making with Discipline.
Deal-Making with Discipline.
At Gardner Law, we provide comprehensive legal support for commercial transactions involving FDA-regulated products, technologies, and services. We help FDA-regulated companies structure and execute transactions that move business forward. Whether negotiating sales agreements, navigating M&A, licensing IP, or advising on supply chain and sourcing arrangements, our attorneys bring deep regulatory knowledge and commercial acumen to every deal. We understand the nuances of doing business in regulated industries and provide counsel that balances legal risk with business reality—helping clients close deals with confidence, clarity, and compliance.
.Our team advises life sciences companies across the full lifecycle of commercial deals—from contract negotiation to execution, compliance, and dispute resolution.
Whether you're bringing a new product to market, scaling operations, or navigating a the buy- or sell-side of an acquisition, we help structure transactions that protect your interests and align with your business goals, while accounting for the FDA-regulated industry's unique regulatory, privacy, and compliance requirements.
Representative Matters Include:
- Commercial Due Diligence in Regulated Transactions
-
Procurement and Vendor Agreement Review
-
Contract Risk Assessments and Compliance Integration
-
SaaS and Software Licensing Agreements
-
Clinical Trial Agreements and Site Contracts
Drafting and Negotiation of Commercial Contracts
Mergers, Acquisitions, and Divestitures
Licensing and Technology Transfer Agreements
Co-Promotion and Co-Marketing Agreements
- Commercial Contract Playbook Development and Training
- Distribution, Reseller, and Commercialization Agreements
- Manufacturing, Supply Chain, and Quality Agreements
- IP and Data Rights Allocation in Commercial Agreements
- Strategic Collaborations and Joint Ventures
- Manufacturing and supply agreements
- Quality and technical agreements
- Clinical trial and facility use agreements
- Licensing and distribution contracts
- Master service agreements (MSAs) and statements of work (SOWs)
- Purchase and sale agreements
- Product sale agreements involving complex rebate structures
- Confidentiality and non-disclosure agreements (NDAs)
- Consulting and independent contractor agreements
- Asset purchase and merger agreements, as well as due diligence reviews.
- Co-promotion and co-marketing agreements
- Development agreements
- Technology and Software as a Service (SaaS) agreements
- Business associate agreements and data security or privacy agreements
- Other commercial contracts required by FDA-regulated businesses.